Access Purchased Content

General Psychiatry
General Psychiatry RSS Feed RSS

Mood, Cognition, and Metabolic Health

March 26, 2021
Rodrigo Barbachan Mansur, MD
Rodrigo Barbachan Mansur, MDRodrigo Barbachan Mansur, MD

Assistant Professor, Division of Brain and Therapeutics, University of Toronto. Dr. Mansur has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Does eszopiclone (Lunesta) have therapeutic effects beyond insomnia? Possibly in depression and anxiety, but the jury is still out in PTSD.
Read More
CLINICAL UPDATE

Six Tips for Working With Older Adults

March 26, 2021
Rehan Aziz, MD.
Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Rehan Aziz, MD, explains how to interview older adults and which medications to use and which ones to avoid in this population.
Read More

TMS Treatment for Depression: An Update

March 11, 2021
Adam Strassberg, MD.
Adam Strassberg, MD. Psychiatrist, private practice. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Transcranial magnetic stimulation is no longer just for depression, with 6 FDA approvals and 7 different devices to choose from. Adam Strassberg looks at how well this intervention stacks up against ECT and medications. Includes a buyer’s guide to the latest machines.
Read More

How to Come Off a Psych Med Part 2: Antidepressants, Stimulants, and Benzos

March 11, 2021
Swapnil Gupta, MD
Swapnil Gupta, MDSwapnil Gupta, MD

Associate Professor at Icahn School of Medicine at Mount Sinai. Co-author of Deprescribing in Psychiatry (Oxford, 2019). Dr. Gupta has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What do you do when a patient comes to you on a high dose of Adderall and Klonopin without any clear reason to be on them? Swapnil Gupta tackles this in part II of our interview on deprescribing, and describes how to fine-tune and microdose antidepressants and benzodiazepines to manage withdrawal symptoms.
Read More

A Closer Look at Alpha-2 Agonists for ADHD

March 11, 2021
Jason Mallo, DO
C. Jason Mallo, DO. Attending Psychiatrist, Maine Medical Center, Portland, Maine. Dr. Mallo has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Now that guanfacine ER (Intuniv) and clonidine ER (Kapvay) have gone generic, we review the 40-years of research that earned them FDA approval in ADHD. Along the way we’ll consider their off-label use in anxiety, addiction, insomnia, and self-harm. Plus: When to use the ER, the instant release, or the oft-forgotten transdermal patch.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.